Veranex

Patient-Centric and Ecosystem Insights into Hepatocellular Carcinoma across Asia-Pacific

Fullscreen Mode

Read More

Recent Study Co-Authored by Veranex to be Presented at ISPOR 2024

225,000 vitrectomy surgeries are performed annually in the U.S. A time-driven cost analysis conducted at a US academic hospital found the average...

Read More

Study Co-Authored by Veranex Found that Mobile Cardiac Outpatient Telemetry (MCOT) was Associated with Lower Readmissions and Healthcare Costs in Post-Stroke Monitored Patients, Compared to Implantabl

This study compares the health and economic outcomes of using mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders (ILRs) for...

Read More

Study by Veranex and Alcon Highlights Time Efficiencies for Femtosecond Laser-Assisted Cataract Surgery

Veranex’s Commercial Strategy team partnered with Alcon in 2020 to design and execute a time-and-motion study comparing Alcon’s femtosecond laser...

Read More

3 min read

Amending Regulation for MDR / IVDR: Key Takeaways for the Diagnostics Industry

Yesterday, the EU Parliament adopted the regulation amending EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to protect patients by ensuring the...

Read More

A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

In this webinar, experts from Goldbug Strategies and Veranex discuss available regulatory pathways for bringing a new generation of innovative...

Read More

Webinar – 2024 IVDR Sprint Series: Usability and Human Factors: Cornerstones of Near Patient Testing – Insights and Perspectives from a Notified Body

Near-patient testing (NPT) devices face substantial challenges under the new IVDR, including: New Stringent Regulatory Constraints due to IVDR...

Read More